Schüpbach J, Kalyanaraman V S
Swiss National Center for Retroviruses, University of Zurich, Switzerland.
Int J Cancer. 1989 Jul 15;44(1):90-4. doi: 10.1002/ijc.2910440117.
Circulating immune complexes from sera of 6 patients with adult T-cell leukemia and 8 asymptomatic carriers infected with the human T-cell leukemia virus type 1 (HTLV-1) were precipitated with polyethylene glycol, and the precipitates were tested for the presence of viral antigen p24 by Western blot, using affinity-purified radiolabelled goat antibody to p24 as a probe. p24 and a larger protein of Mr 45,000 immunologically related to p24 were detected at concentrations of up to 100-200 ng/ml in one of the carriers, while all other samples were negative. The concentration of the Mr 45,000 protein in the immune complexes was considerably higher than that of p24. Analysis of an HTLV-1 producer cell line, G-11/MJ, by competition Western blots and gag-specific antibodies, showed the presence of a hitherto unrecognized viral protein p45 which contains both p19 and p24 and probably represents an intermediate precursor of these proteins. The results present direct evidence of production of HTLV-1 proteins in an asymptomatically infected individual.
用聚乙二醇沉淀6例成人T细胞白血病患者及8例感染1型人类T细胞白血病病毒(HTLV-1)的无症状携带者血清中的循环免疫复合物,以亲和纯化的放射性标记山羊抗p24抗体为探针,通过蛋白质印迹法检测沉淀物中病毒抗原p24的存在。在其中一名携带者中,检测到浓度高达100 - 200 ng/ml的p24以及一种与p24免疫相关的45,000道尔顿的较大蛋白质,而所有其他样本均为阴性。免疫复合物中45,000道尔顿蛋白质的浓度显著高于p24。通过竞争蛋白质印迹法和gag特异性抗体对HTLV-1产生细胞系G-11/MJ进行分析,结果显示存在一种迄今未被识别的病毒蛋白p45,它包含p19和p24,可能是这些蛋白质的中间前体。这些结果提供了无症状感染个体产生HTLV-1蛋白的直接证据。